Suchergebnisse - "Loveless, James"

PubPharm (5)

1

Treatment patterns in US patients hospitalized with COVID-19 and pulmonary involvement

enthalten in: Journal of medical virology | 2021

von Best, J. | Kong, A. | Kaplan-Lewis, E. | +7

2

Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis : Sixteen-Week Results From a Phase III Randomized, Double-Blind, Placebo-Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2019

von Deodhar, A. | Poddubnyy, D. | Pacheco-Tena, C. | +94

3

Multiple courses of rituximab produce sustained clinical and radiographic efficacy and safety in patients with rheumatoid arthritis and an inadequate response to 1 or more tumor necrosis factor inhibitors : 5-year data from the REFLEX study

enthalten in: The Journal of rheumatology | 2012

von Keystone, E. | Cohen, S. | Emery, P. | +7

CommentIn: J Rheumatol. 2013 May;40(5):732. - PMID 23637377

4

Abetimus sodium for renal flare in systemic lupus erythematosus : results of a randomized, controlled phase III trial

enthalten in: Arthritis and rheumatism | 2008

von Cardiel, M. | Tumlin, J. | Furie, R. | +93

5

Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy : Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks

enthalten in: Arthritis and rheumatism | 2006

von Cohen, S. | Emery, P. | Greenwald, M. | +11

1
[1]